Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial breast irradiation: revolution or evolution?

J M Hannoun-Levi1, J J Mazeron, H Marsiglia

  • 1Department of Radiation Oncology, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France. jean-michel.hannoun-levi@fccc.edu

Cancer Treatment Reviews
|November 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salvage brachytherapy for local recurrence of cancer after definitive irradiation: a GEC-ESTRO narrative review.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Radiobiology and modelling in Brachytherapy: A review inspired by the ESTRO Brachytherapy pre-meeting course.

Clinical and translational radiation oncology·2024
Same author

Randomized trials: When scientific rigor meets field reality.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Same author

The current status of brachytherapy in Europe - A GEC-ESTRO Brachy-HERO survey.

Clinical and translational radiation oncology·2024
Same author

A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Catheter removal after interstitial brachytherapy for breast cancer: Feasibility study for task delegation.

Technical innovations & patient support in radiation oncology·2024
Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026
Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026
Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026
Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026
Same journal

Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.

Cancer treatment reviews·2026
See all related articles

Partial breast irradiation (PBI) shows promising local control and cosmetic results for select breast cancer patients. Further follow-up is needed, but PBI may offer a new therapeutic option for low-risk cases.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Mastectomy and radio-surgical conservative treatment (RSCT) show similar overall survival rates in breast cancer.
  • Partial breast irradiation (PBI) emerged in the late 1990s as a potential alternative to whole breast irradiation.
  • Ongoing phase III trials are comparing whole breast irradiation with PBI.

Purpose of the Study:

  • To review literature on breast cancer irradiation and the role of PBI in preventing local recurrence.
  • To discuss the advantages and limitations of PBI.
  • To identify patient subgroups who may benefit from PBI.

Main Methods:

  • Literature review of phase II and III trials on PBI feasibility, efficacy, and toxicity.
  • Analysis of PBI delivery methods including brachytherapy and external beam radiation.

Related Experiment Videos

  • Evaluation of recurrence rates and cosmetic outcomes.

    • Main Results:

    • PBI, delivered via brachytherapy or external beam, meets quality control criteria.
    • Most studies report PBI recurrence rates below 5% (0-4.4%) with a median follow-up of 8-72 months.
    • Cosmetic results with PBI are comparable to conventional external beam radiation therapy.

    Conclusions:

    • PBI shows encouraging preliminary results for local control and cosmesis in breast cancer.
    • PBI is not a replacement for conventional treatment but a potential strategy for well-defined, low-risk patient subgroups.
    • Longer follow-up is necessary to confirm the efficacy and safety of PBI.